S4039 A Rare Case of Lymphatic Malformations Presenting as Protein-Losing Enteropathy and Literature Review

Introduction: Lymphatic malformations (LMs) are rare, benign tumors characterized by abnormal proliferation of lymphatic vessels. Abdominal LMs account for less than 5% of all LMs.1 This is the first case of an adult with abdominal LMs causing protein-losing enteropathy that was treated with dietary changes alone. Case Description/Methods: A 24-year-old woman without significant past medical history presented with chronic diarrhea and weight loss. Labs showed hypoalbuminemia, low fecal calprotectin, normal fecal elastase, and elevated fecal Alpha-1-Antitrypsin (A1AT). Abdominal computed tomography was concerning for mucinous carcinomatosis or pseudomyxoma peritonei with fluid signal involving the colon and pancreas. Upper endoscopic ultrasound showed hyperechoic spaces surrounding the pancreas. Attempted aspiration of the spaces was unsuccessful. Colonoscopy showed an edematous cecum with the appearance of extrinsic compression. The biopsies from esophagogastroduodenoscopy and colonoscopy were negative. An omental biopsy was negative for carcinomatosis but showed changes most consistent with a diagnosis of abdominal LMs. With dietary changes, the patient reported 85%-90% improvement in symptoms. Discussion: LMs can lead to impaired lymphatic drainage and dilation of lymphatic vessels (lymphangiectasia). Abdominal lymphangiectasias can lead to protein-losing enteropathy, resulting in hypoproteinemia and elevated fecal A1AT. Symptomatic patients are often treated with surgical resection or sclerotherapy.1,2 For this patient, these interventions were not performed due to the diffuse nature of LMs with no identifiable cystic masses. For non-procedural candidates, Sirolimus (an mTOR inhibitor), which inhibits lymphangiogenesis, can be used.2 To treat the protein-losing enteropathy, a low-fat, high-protein diet supplemented by medium chain triglycerides (MCTs) can be trialed. In this case, the patient experienced significant improvement in symptoms and stool burden with dietary changes. In adults, abdominal LMs are often asymptomatic with the majority discovered incidentally.1 Our literature review resulted only a handful of symptomatic adult cases, and all were managed surgically. This is the first reported adult case of protein-losing enteropathy due to abdominal LMs that was treated with dietary changes alone. References 1. Hoang et al. Japanese Journal of Radiology. July 2022. 283-302. 2. Leboulanger N, Bisdorff A, Boccara O, et al. French national diagnosis and care protocol (PNDS, protocole national de diagnostic et de soins): cystic lymphatic malformations. Orphanet J Rare Dis. 2023 Jan 13;18(1):10.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001143616.31434.71
Primary Topic
Vascular Malformations and Hemangiomas
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S4039 A Rare Case of Lymphatic Malformations Presenting as Protein-Losing Enteropathy and Literature Review

Katerina Roma, J Thomas, Ishfaq Bhat
The American Journal of Gastroenterology
Vascular Malformations and Hemangiomas
article

S4039 A Rare Case of Lymphatic Malformations Presenting as Protein-Losing Enteropathy and Literature Review

Katerina Roma, J Thomas, Ishfaq Bhat
article en

Abstract

Introduction: Lymphatic malformations (LMs) are rare, benign tumors characterized by abnormal proliferation of lymphatic vessels. Abdominal LMs account for less than 5% of all LMs.1 This is the first case of an adult with abdominal LMs causing protein-losing enteropathy that was treated with dietary changes alone. Case Description/Methods: A 24-year-old woman without significant past medical history presented with chronic diarrhea and weight loss. Labs showed hypoalbuminemia, low fecal calprotectin, normal fecal elastase, and elevated fecal Alpha-1-Antitrypsin (A1AT). Abdominal computed tomography was concerning for mucinous carcinomatosis or pseudomyxoma peritonei with fluid signal involving the colon and pancreas. Upper endoscopic ultrasound showed hyperechoic spaces surrounding the pancreas. Attempted aspiration of the spaces was unsuccessful. Colonoscopy showed an edematous cecum with the appearance of extrinsic compression. The biopsies from esophagogastroduodenoscopy and colonoscopy were negative. An omental biopsy was negative for carcinomatosis but showed changes most consistent with a diagnosis of abdominal LMs. With dietary changes, the patient reported 85%-90% improvement in symptoms. Discussion: LMs can lead to impaired lymphatic drainage and dilation of lymphatic vessels (lymphangiectasia). Abdominal lymphangiectasias can lead to protein-losing enteropathy, resulting in hypoproteinemia and elevated fecal A1AT. Symptomatic patients are often treated with surgical resection or sclerotherapy.1,2 For this patient, these interventions were not performed due to the diffuse nature of LMs with no identifiable cystic masses. For non-procedural candidates, Sirolimus (an mTOR inhibitor), which inhibits lymphangiogenesis, can be used.2 To treat the protein-losing enteropathy, a low-fat, high-protein diet supplemented by medium chain triglycerides (MCTs) can be trialed. In this case, the patient experienced significant improvement in symptoms and stool burden with dietary changes. In adults, abdominal LMs are often asymptomatic with the majority discovered incidentally.1 Our literature review resulted only a handful of symptomatic adult cases, and all were managed surgically. This is the first reported adult case of protein-losing enteropathy due to abdominal LMs that was treated with dietary changes alone. References 1. Hoang et al. Japanese Journal of Radiology. July 2022. 283-302. 2. Leboulanger N, Bisdorff A, Boccara O, et al. French national diagnosis and care protocol (PNDS, protocole national de diagnostic et de soins): cystic lymphatic malformations. Orphanet J Rare Dis. 2023 Jan 13;18(1):10.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 48%
Vascular Malformations and Hemangiomas
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.